This is a synthetic peptide designed for use in combination with anti-Gabra5 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
GABRA5
(gamma-aminobutyric Acid (GABA) A Receptor, alpha 5 (GABRA5))
Synonyme
GABRA5 Peptide, si:dkey-93p24.1 Peptide, A230018I05Rik Peptide, gamma-aminobutyric acid type A receptor alpha5 subunit Peptide, gamma-aminobutyric acid (GABA) A receptor, alpha 5 Peptide, gamma-aminobutyric acid type A receptor alpha 5 subunit Peptide, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5 Peptide, gamma-aminobutyric acid receptor subunit alpha-5 Peptide, GABRA5 Peptide, gabra5 Peptide, Gabra5 Peptide, LOC100653497 Peptide
Hintergrund
GABA, the major inhibitory neurotransmitter in the vertebrate brain, mediates neuronal inhibition by binding to the GABA/benzodiazepine receptor and opening an integral chloride channel.